Low 1-Year Cyclosporine Microemulsion Doses Are Associated With Better 5-Year Renal Graft Function: An Insight From MOST, a Multinational Observational Study

Transplantation Proceedings

Volumn 38, Issue 4, 2006, Pages 1010-1013

  Salvadori, M ^a   Rosati, A ^a   Bertoni, E ^a   Bock, A ^b   Chapman, J ^c   Dussol, B ^d   Fritsche, L ^e   Kliem, V ^f   Lebranchu, Y ^g   Oppenheimer, F ^h   Pohanka, E ⁱ   Tufveson, G ^j   Soergel, M ^k  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Kantonospital   (Switzerland)

^c WESTMEAD HOSPITAL   (Australia)

^d HÔPITAL DE LA CONCEPTION   (France)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f Nephrologisches Zentrum Niedersachsen   (Germany)

^g UNIVERSITY HOSPITAL OF TOURS   (France)

^h HOSPITAL CLÍNIC   (Spain)

ⁱ MEDICAL UNIVERSITY OF VIENNA   (Austria)

^j UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^k NOVARTIS PHARMA AG   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; ARTICLE; CADAVER DONOR; CADAVER KIDNEY; CONTROLLED STUDY; COVARIANCE; DATA ANALYSIS; DONOR; DRUG MEGADOSE; GLOMERULUS FILTRATION RATE; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MICROEMULSION; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANK SUM TEST; RISK FACTOR; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AGED; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMULSIONS; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEAST-SQUARES ANALYSIS; MIDDLE AGED; TIME FACTORS; TISSUE DONORS;

EID: 33744821872     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.03.060     Document Type: Article

References (6)

1. Opelz G., and Dohler B. Cyclosporine and long-term kidney graft survival. Transplantation 72 (2001) 1267
2. Keown P., and Niese D. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. Kidney Int 54 (1998) 938
3. Pollard S.G., Lear P.A., and Ready A.R. Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. Transplantation 68 (1999) 1325
4. Ahsan N., Johnson C., and Gonwa T. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric renal transplantation. results at 2 years. Transplantation 72 (2001) 245
5. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31
6. Nankivell B.J., Borrows R.J., and Fung C.L. Calcineurin inhibitor nephrotoxicity. longitudinal assessment by protocol histology. Transplantation 78 (2004) 557